Your browser doesn't support javascript.
loading
NAD(P)H: quinone oxidoreductase 1 activatable toll-like receptor 7/8 agonist designed for precise immunotherapy.
Li, Guo; Xu, Yongxiao; Kong, Xiaojie; Gu, Liuwei; Qin, Yuling; Wu, Li.
Afiliação
  • Li G; Nantong Key Laboratory of Public Health and Medical Analysis, School of Public Health, Nantong University, No. 9, Seyuan Road, Nantong 226019, Jiangsu, P. R. China. ylqin@ntu.edu.cn.
  • Xu Y; Nantong Key Laboratory of Public Health and Medical Analysis, School of Public Health, Nantong University, No. 9, Seyuan Road, Nantong 226019, Jiangsu, P. R. China. ylqin@ntu.edu.cn.
  • Kong X; Nantong Key Laboratory of Public Health and Medical Analysis, School of Public Health, Nantong University, No. 9, Seyuan Road, Nantong 226019, Jiangsu, P. R. China. ylqin@ntu.edu.cn.
  • Gu L; Nantong Key Laboratory of Public Health and Medical Analysis, School of Public Health, Nantong University, No. 9, Seyuan Road, Nantong 226019, Jiangsu, P. R. China. ylqin@ntu.edu.cn.
  • Qin Y; Nantong Key Laboratory of Public Health and Medical Analysis, School of Public Health, Nantong University, No. 9, Seyuan Road, Nantong 226019, Jiangsu, P. R. China. ylqin@ntu.edu.cn.
  • Wu L; Nantong Key Laboratory of Public Health and Medical Analysis, School of Public Health, Nantong University, No. 9, Seyuan Road, Nantong 226019, Jiangsu, P. R. China. ylqin@ntu.edu.cn.
Chem Commun (Camb) ; 59(42): 6343-6346, 2023 May 23.
Article em En | MEDLINE | ID: mdl-37132604

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article